StonvexLoading…
StonvexStonvexStonvexCore line items from UBXG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $29.67M | $51.60M | $94.32M | $86.68M |
Operating Income | $-3.11M | $-872.89K | $153.90K | $126.65K |
Net Income | $-2.72M | $-748.54K | $205.91K | $-49.02K |
EPS (Diluted) | $-0.37 | $-0.48 | $0.16 | $0.00 |
Total Assets | $20.98M | $16.79M | $4.85M | Not available |
Total Liabilities | $1.96M | $2.92M | $3.78M | Not available |
Cash & Equivalents | $11.18M | $4.83M | $1.29M | $1.52M |
Free Cash Flow OCF − CapEx | Not available | $-1.37M | $-285.81K | $360.14K |
Shares Outstanding | 20.78M | 1.69M | 24.00M | 23.13M |